References
- Yan TD, Welch L, Black D, Sugarbaker PH. (2007). A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol 18:827–34.
- Jacquet P, Sugarbaker PH. (1996). Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359–74.
- Elias D, Gilly F, Quenet F, et al. (2010). Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol 36:456–62.
- Chua TC, Moran BJ, Sugarbaker PH, et al. (2012). Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30:2449–56.
- Faron M, Macovei R, Goere D, et al. (2016). Linear relationship of peritoneal cancer index and survival in patients with peritoneal metastases from colorectal cancer. Ann Surg Oncol 23:114–19.
- Sun JH, Ji ZH, Peng KW, et al. (2016). Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for the treatment of primary peritoneal serous carcinoma: results of a Chinese retrospective study. Int J Hyperthermia 32:289–97.
- Bosman FT, Carneiro F, Hruban RH, Theise ND. (2010). WHO classification of tumours of the digestive system. 4th ed. Geneva, Switzerland: International Agency for Research on Cancer.
- Carr NJ, McCarthy WF, Sobin LH. (1995). Epithelial noncarcinoid tumors and tumor-like lesions of the appendix. A clinicopathologic study of 184 patients with a multivariate analysis of prognostic factors. Cancer 75:757–68.
- Nitsche U, Zimmermann A, Spath C, et al. (2013). Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosis. Ann Surg 258:775–82; discussion 82–3.
- Catalano V, Loupakis F, Graziano F, et al. (2009). Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy. Br J Cancer 100:881–7.
- Razenberg LG, van Gestel YR, Lemmens VE, et al. (2015). The prognostic relevance of histological subtype in patients with peritoneal metastases from colorectal cancer: a nationwide population-based study. Clin Colorectal Cancer 14:e13–19.
- da Silva RG, Sugarbaker PH. (2006). Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. J Am Coll Surg 203:878–86.
- van Oudheusden TR, Braam HJ, Nienhuijs SW, et al. (2015). Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology. J Surg Oncol 111:237–42.
- Mekenkamp LJ, Heesterbeek KJ, Koopman M, et al. (2012). Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer. Eur J Cancer 48:501–9.
- Negri FV, Wotherspoon A, Cunningham D, et al. (2005). Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer. Ann Oncol 16:1305–10.
- Polanco PM, Sanchez AI, Ramalingam L, et al. (2014). Does obesity affect outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for disseminated mucinous appendiceal neoplasms? Ann Surg Oncol 21:3963–9.
- Tran AQ, Cohen JG, Li AJ. (2015). Impact of obesity on secondary cytoreductive surgery and overall survival in women with recurrent ovarian cancer. Gynecol Oncol 138:263–6.
- Beaton C, Twine CP, Williams GL, Radcliffe AG. (2013). Systematic review and meta-analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer. Colorectal Dis 15:788–97.
- Goere D, Souadka A, Faron M, et al. (2015). Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study. Ann Surg Oncol 22:2958–64.
- Elias D, Blot F, El Otmany A, et al. (2001). Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92:71–6.
- Tan G, Chia C, Kumar M, et al. (2017). 201 consecutive cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) procedures in a single Asian tertiary centre. Int J Hyperthermia 33:288–94.
- Pelz JO, Stojadinovic A, Nissan A, et al. (2009). Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosis. J Surg Oncol 99:9–15.